| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/26/2001 | WO2001028603A1 Formulations for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028602A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028600A1 Conveyance of anti-infective activity to wound dressings |
| 04/26/2001 | WO2001028593A2 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | WO2001028591A2 Injection vehicle for polymer-based formulations |
| 04/26/2001 | WO2001028586A1 Method of treating fibrosis |
| 04/26/2001 | WO2001028584A1 Treatment of respiratory diseases and infections |
| 04/26/2001 | WO2001028582A2 Therapeutic applications of flint polypeptides |
| 04/26/2001 | WO2001028581A1 Medicinal compositions for inhibiting gvhd |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028578A2 A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME |
| 04/26/2001 | WO2001028577A2 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 04/26/2001 | WO2001028576A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 04/26/2001 | WO2001028574A2 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | WO2001028544A2 Dialysis solution including polyglycol osmotic agent |
| 04/26/2001 | WO2001028539A2 Agent for treating cephalic pain |
| 04/26/2001 | WO2001028533A2 PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA |
| 04/26/2001 | WO2001028532A2 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 04/26/2001 | WO2001028530A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | WO2001028529A1 Pharmaceutical products and methods of fabrication therefor |
| 04/26/2001 | WO2001028525A2 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | WO2001028520A1 Microemulsion preconcentrates, microemulsion and use of such a composition |
| 04/26/2001 | WO2001028519A1 Microemulsion preconcentrates and microemulsions |
| 04/26/2001 | WO2001028518A1 Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions |
| 04/26/2001 | WO2001028509A1 Depilatories and agents for external use |
| 04/26/2001 | WO2001028500A2 Uses of antileukoprotease in carcinoma |
| 04/26/2001 | WO2001028356A2 Food supplement for increasing lean mass and strength |
| 04/26/2001 | WO2001028353A2 Protein hydrolysates produced with the use of marine proteases |
| 04/26/2001 | WO2001028321A1 Diabetes onset model mammal |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000074703A3 Therapeutic agent comprising a botulinum neurotoxin |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000071153A3 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000061574A3 Method for producing thiophenyl-amidines |
| 04/26/2001 | WO2000061121A3 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000054799A3 Medicament for treating diabetes |
| 04/26/2001 | WO2000051628A3 Methods of modulating lipid metabolism and storage |
| 04/26/2001 | WO1997035884A8 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies |
| 04/26/2001 | US20010000510 Electrostatic bonding type macromolecular micelle drug carrier and carried thereon |
| 04/26/2001 | DE19951072A1 New cell constructs from activated T-cells of patients useful as a medicament |
| 04/26/2001 | DE10032444A1 Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388700A1 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | CA2388653A1 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388427A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | CA2388386A1 A new eag gene |
| 04/26/2001 | CA2388357A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 04/26/2001 | CA2388315A1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | CA2388166A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | CA2388003A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | CA2387962A1 A dna molecule encoding a variant .alpha.2b-adrenoceptor protein, and uses thereof |
| 04/26/2001 | CA2387928A1 Genes associated with obesity and methods for using the same |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2387810A1 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | CA2387748A1 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | CA2387646A1 A general method for optimizing the expression of heterologous proteins |
| 04/26/2001 | CA2387559A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | CA2387511A1 Protein-containing granules and granule formulations |
| 04/26/2001 | CA2387185A1 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386476A1 Tms1 compositions and methods of use |
| 04/26/2001 | CA2386408A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | CA2386270A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | CA2385958A1 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | CA2384841A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2384537A1 Modulation of angiogenesis |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2382864A1 Dialysis solution including polyglycol osmotic agent |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094108A2 DNA mutagenesis by random fragmentation and reassembly for antibody production |
| 04/25/2001 | EP1094081A1 Fused protein with direct bond of il-6-receptor to il-6 |
| 04/25/2001 | EP1094079A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094078A2 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1094077A1 Novel sugar chain-bonded thrombomodulin-like peptide |
| 04/25/2001 | EP1094076A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses |
| 04/25/2001 | EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis |
| 04/25/2001 | EP1094072A1 Peptides having corticotropin releasing factor (CRF) antagonist activity |
| 04/25/2001 | EP1094071A1 Novel peptide y-2 |
| 04/25/2001 | EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials |
| 04/25/2001 | EP1094069A1 DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093818A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 04/25/2001 | EP1093811A1 Anti-tumor compositions containing taxan derivatives |
| 04/25/2001 | EP1093720A1 Stable polymerized hemoglobin blood-substitute |
| 04/25/2001 | EP1093522A2 Proteases fused with variants of stretptomyces subtilisin inhibitor |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 04/25/2001 | EP1093517A2 Neisseria meningitidis antigens and compositions |